Federal Government’s Proposed Expansion of Regulation of Biospecimen Research Should Be Reconsidered: New Commentary from Petrie-Flom Fellowship Alumnus Christopher T. Robertson
Note: The full article is behind a paywall.
In September, the U.S. Department of Health and Human Services, together with other federal agencies, announced proposed changes to the rules governing human subjects research. This Commentary discusses how the proposals would affect research using biospecimens that is essential to the future success of precision medicine. We argue that the proposed changes unnecessarily burden such research, without meaningfully advancing the interests of donors. They should be revised before being finalized.
Access the full article online!bioethics biotechnology genetics health law policy human subjects research human tissue innovation regulation research